knowledge -WSS

knowledge

author：Wikipedia 2025-09-04 05:36:39 - browse：56223

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Medical experts are missing from AI regulatory conversations

hotspot

WSS

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Celebrate National Dole Whip Day for 3 days this week at Disney

White House launches permanent pandemic office

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Why an extreme heat and wildfire smoke combination can be so dangerous

leisure time

knowledge

hotspot

Drug repurposing or repositioning? The language matters

Couple fighting to bring baby home from Mexico are finally reunited

Activists slam private health insurers over coverage restrictions

Review: 'Barbie' will hit you like a shot in the heart

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Review: 'Barbie' will hit you like a shot in the heart

Wildfire smoke exposes gaps in outdoor worker protections

New rules on organ donation and transplantation 'will bring chaos'

Heart attack and stroke risk calculators need revising

AbbVie dramatically boosts its spending on lobbying

Wikipedia

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Organ transplantation is at a crossroads. Major reform is needed

Medical experts are missing from AI regulatory conversations

Medical experts are missing from AI regulatory conversations

India sets sights on home

Plane’s emergency slide plummets from sky, hits Chicago home

hotspot

focus

hotspot

hotspot